Harry Silvers
Head of Investor Relations
Replay available
United Therapeutics Corporation (UTHR) Q1 2026 Earnings Call
United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Martine Rothblatt
Chairperson and Chief Executive Officer
Michael Bankowitz
President and Chief Operating Officer
Dr. Lee Peterson
Executive Vice President of Product Development and Xenotransplantation
Pat Poisson
Executive Vice President of Strategic Development
Ash Verma
Analyst, UBS
Rolanda Ruiz
Analyst, Leerink Partners
Joseph Thorne
Analyst, TD Cowen
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for United Therapeutics Corporation.
Replay transcript excerpt
WEBVTT 00:00:01.752 -- 00:00:06.937 Good morning and welcome to the United Therapeutics Corporation First Quarter 2026 Corporate 00:00:06.937 -- 00:00:10.380 Update. My name is Yale and I will be your operator today. 00:00:10.380 -- 00:00:15.384 All participants on the call portion of this webcast will be in listen-only mode 00:00:15.384 -- 00:00:19.107 until the question and answer portion of this earnings call. 00:00:19.107 -- 00:00:22.550 If you would like to ask a question during that time, simply press star, then the number 00:00:22.550 -- 00:00:26.373 1 on your telephone keypad. If you would like to withdraw your question, simply press 00:00:26.373 -- 00:00:29.456 star and the number 1 again on your telephone keypad. 00:00:29.456 -- 00:00:32.347 Please note that this call is being recorded. 00:00:32.347 -- 00:00:37.812 I'll now turn the webcast over to Harry Silvers, Investor Relations at United. 00:00:38.937 -- 00:00:43.684 Thank you, J.L. Good morning. It is my pleasure to welcome you to the United Therapeutics 00:00:43.684 -- 00:00:48.231 Corporation First Quarter 2026 Corporate Update webcast. 00:00:48.231 -- 00:00:52.518 Remarks today will include forward-looking statements representing our expectations or 00:00:52.518 -- 00:00:57.165 beliefs regarding future events. These statements involve risks and uncertainties that 00:00:57.165 -- 00:01:00.022 may cause actual results to differ materially. 00:01:00.022 -- 00:01:05.148 Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information 00:01:05.148 -- 00:01:10.215 on these risks and uncertainties. We assume no obligation to update forward-looking statements. 00:01:10.215 -- 00:01:14.840 Today's remarks may discuss the progress and results of clinical trials or other developments 00:01...